These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15096536)

  • 1. Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.
    Lathem WW; Bergsbaken T; Welch RA
    J Exp Med; 2004 Apr; 199(8):1077-87. PubMed ID: 15096536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor.
    Lathem WW; Grys TE; Witowski SE; Torres AG; Kaper JB; Tarr PI; Welch RA
    Mol Microbiol; 2002 Jul; 45(2):277-88. PubMed ID: 12123444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the StcE protease activity of Escherichia coli O157:H7.
    Grys TE; Walters LL; Welch RA
    J Bacteriol; 2006 Jul; 188(13):4646-53. PubMed ID: 16788173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of stcE, a C1 esterase inhibitor-specific metalloprotease, during the evolution of Escherichia coli O157:H7.
    Lathem WW; Bergsbaken T; Witowski SE; Perna NT; Welch RA
    J Infect Dis; 2003 Jun; 187(12):1907-14. PubMed ID: 12792867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells.
    Grys TE; Siegel MB; Lathem WW; Welch RA
    Infect Immun; 2005 Mar; 73(3):1295-303. PubMed ID: 15731026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional characterization of a ToxR-regulated lipoprotein from a clinical isolate of Aeromonas hydrophila.
    Pillai L; Sha J; Erova TE; Fadl AA; Khajanchi BK; Chopra AK
    Infect Immun; 2006 Jul; 74(7):3742-55. PubMed ID: 16790746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7.
    Szabady RL; Lokuta MA; Walters KB; Huttenlocher A; Welch RA
    PLoS Pathog; 2009 Feb; 5(2):e1000320. PubMed ID: 19247439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ; Kasper DL
    J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.
    Wijeyewickrema LC; Lameignere E; Hor L; Duncan RC; Shiba T; Travers RJ; Kapopara PR; Lei V; Smith SA; Kim H; Morrissey JH; Pike RN; Conway EM
    Blood; 2016 Sep; 128(13):1766-76. PubMed ID: 27338096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement 1 inhibitor is a regulator of the alternative complement pathway.
    Jiang H; Wagner E; Zhang H; Frank MM
    J Exp Med; 2001 Dec; 194(11):1609-16. PubMed ID: 11733575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma membrane profiling during enterohemorrhagic
    Furniss RCD; Low WW; Mavridou DAI; Dagley LF; Webb AI; Tate EW; Clements A
    J Biol Chem; 2018 Nov; 293(44):17188-17199. PubMed ID: 30190327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A postulated mechanism for heparin's potentiation of C1 inhibitor function.
    Caughman GB; Boackle RJ; Vesely J
    Mol Immunol; 1982 Feb; 19(2):287-95. PubMed ID: 7099168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
    Jansen PM; Eisele B; de Jong IW; Chang A; Delvos U; Taylor FB; Hack CE
    J Immunol; 1998 Jan; 160(1):475-84. PubMed ID: 9552006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional aspects of C1-inhibitor.
    Bos IG; Hack CE; Abrahams JP
    Immunobiology; 2002 Sep; 205(4-5):518-33. PubMed ID: 12396012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.
    Landsem A; Nielsen EW; Fure H; Christiansen D; Ludviksen JK; Lambris JD; Østerud B; Mollnes TE; Brekke OL
    Clin Exp Immunol; 2013 Aug; 173(2):217-29. PubMed ID: 23607270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.
    Poppelaars F; Damman J; de Vrij EL; Burgerhof JG; Saye J; Daha MR; Leuvenink HG; Uknis ME; Seelen MA
    Clin Exp Immunol; 2016 Jun; 184(3):378-88. PubMed ID: 26874675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.